Robin Shane Readnour

CIK: 0001914883

Transaction Breakdown

Open Market Buys (P)14 (48.3%)

High conviction signal

Open Market Sales (S)8 (27.6%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (17.2%)

Compensation grants

Other (G, F, J, C, D, …)2 (6.9%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ANTX

AN2 Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (29 total)

ANTX
AN2 Therapeutics, Inc.
Sep 9, 2026
Sale(S)
Indirect
523 shares at avg. $6.02$3K
ANTX
AN2 Therapeutics, Inc.
Sep 9, 2026
Sale(S)
Indirect
585 shares at avg. $6.02$4K
ANTX
AN2 Therapeutics, Inc.
Sep 8, 2026
Sale(S)
Indirect
4.7K shares at avg. $6.02$28K
ANTX
AN2 Therapeutics, Inc.
Sep 8, 2026
Sale(S)
Indirect
5.3K shares at avg. $6.02$32K
ANTX
AN2 Therapeutics, Inc.
Sep 3, 2026
Sale(S)
Indirect
3.2K shares at avg. $6.07$20K
ANTX
AN2 Therapeutics, Inc.
Sep 3, 2026
Sale(S)
Indirect
2.9K shares at avg. $6.07$17K
ANTX
AN2 Therapeutics, Inc.
Aug 17, 2026
Sale(S)
Indirect
18.7K shares at avg. $6.01$112K
ANTX
AN2 Therapeutics, Inc.
Aug 17, 2026
Sale(S)
Indirect
16.7K shares at avg. $6.01$100K
ANTX
AN2 Therapeutics, Inc.
Mar 19, 2026
Disposition(D)
Stock Option (right to buy)
Direct
23.7K shares-
ANTX
AN2 Therapeutics, Inc.
Mar 19, 2026
Award(A)
Stock Option (right to buy)
Direct
20.7K shares-
ANTX
AN2 Therapeutics, Inc.
Mar 19, 2026
Disposition(D)
Stock Option (right to buy)
Direct
20.7K shares-
ANTX
AN2 Therapeutics, Inc.
Mar 19, 2026
Award(A)
Stock Option (right to buy)
Direct
23.7K shares-
ANTX
AN2 Therapeutics, Inc.
Feb 20, 2026
Award(A)
Stock Option (Right to Buy)
Direct
20.4K shares-
ANTX
AN2 Therapeutics, Inc.
May 22, 2025
Award(A)
Stock Option (Right to Buy)
Direct
19.1K shares-
ANTX
AN2 Therapeutics, Inc.
Dec 19, 2024
Award(A)
Direct
9.1K shares-
ANTX
AN2 Therapeutics, Inc.
Dec 10, 2024
Purchase(P)
Indirect
5K shares at avg. $1.49$7K
ANTX
AN2 Therapeutics, Inc.
Dec 10, 2024
Purchase(P)
Indirect
5K shares at avg. $1.49$7K
ANTX
AN2 Therapeutics, Inc.
Dec 9, 2024
Purchase(P)
Indirect
18.5K shares at avg. $1.43$26K
ANTX
AN2 Therapeutics, Inc.
Dec 9, 2024
Purchase(P)
Indirect
12.3K shares at avg. $1.43$18K
ANTX
AN2 Therapeutics, Inc.
Dec 6, 2024
Purchase(P)
Indirect
6.5K shares at avg. $1.45$9K
ANTX
AN2 Therapeutics, Inc.
Dec 6, 2024
Purchase(P)
Indirect
12.7K shares at avg. $1.45$18K
ANTX
AN2 Therapeutics, Inc.
Nov 27, 2024
Purchase(P)
Indirect
25K shares at avg. $1.42$35K
ANTX
AN2 Therapeutics, Inc.
Nov 27, 2024
Purchase(P)
Indirect
25K shares at avg. $1.42$35K
ANTX
AN2 Therapeutics, Inc.
Nov 26, 2024
Purchase(P)
Indirect
12.5K shares at avg. $1.39$17K
ANTX
AN2 Therapeutics, Inc.
Nov 26, 2024
Purchase(P)
Indirect
12.5K shares at avg. $1.39$17K

		Type	Shares	Price		Ownership
Sep 9, 2026	ANTX AN2 Therapeutics, Inc.	Sale(S)	523	$6.02	$3,151	Indirect
Sep 9, 2026	ANTX AN2 Therapeutics, Inc.	Sale(S)	585	$6.02	$3,524	Indirect
Sep 8, 2026	ANTX AN2 Therapeutics, Inc.	Sale(S)	4,725	$6.02	$28,436	Indirect
Sep 8, 2026	ANTX AN2 Therapeutics, Inc.	Sale(S)	5,294	$6.02	$31,861	Indirect
Sep 3, 2026	ANTX AN2 Therapeutics, Inc.	Sale(S)	3,223	$6.07	$19,563	Indirect
Sep 3, 2026	ANTX AN2 Therapeutics, Inc.	Sale(S)	2,877	$6.07	$17,463	Indirect
Aug 17, 2026	ANTX AN2 Therapeutics, Inc.	Sale(S)	18,706	$6.01	$112,389	Indirect
Aug 17, 2026	ANTX AN2 Therapeutics, Inc.	Sale(S)	16,696	$6.01	$100,313	Indirect
Mar 19, 2026	ANTX AN2 Therapeutics, Inc.	Disposition(D) Stock Option (right to buy)	23,742	-	-	Direct
Mar 19, 2026	ANTX AN2 Therapeutics, Inc.	Award(A) Stock Option (right to buy)	20,724	-	-	Direct
Mar 19, 2026	ANTX AN2 Therapeutics, Inc.	Disposition(D) Stock Option (right to buy)	20,724	-	-	Direct
Mar 19, 2026	ANTX AN2 Therapeutics, Inc.	Award(A) Stock Option (right to buy)	23,742	-	-	Direct
Feb 20, 2026	ANTX AN2 Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	20,400	-	-	Direct
May 22, 2025	ANTX AN2 Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	19,111	-	-	Direct
Dec 19, 2024	ANTX AN2 Therapeutics, Inc.	Award(A)	9,077	-	$0	Direct
Dec 10, 2024	ANTX AN2 Therapeutics, Inc.	Purchase(P)	5,000	$1.49	$7,462	Indirect
Dec 10, 2024	ANTX AN2 Therapeutics, Inc.	Purchase(P)	5,000	$1.49	$7,468	Indirect
Dec 9, 2024	ANTX AN2 Therapeutics, Inc.	Purchase(P)	18,483	$1.43	$26,407	Indirect
Dec 9, 2024	ANTX AN2 Therapeutics, Inc.	Purchase(P)	12,289	$1.43	$17,577	Indirect
Dec 6, 2024	ANTX AN2 Therapeutics, Inc.	Purchase(P)	6,517	$1.45	$9,427	Indirect
Dec 6, 2024	ANTX AN2 Therapeutics, Inc.	Purchase(P)	12,711	$1.45	$18,367	Indirect
Nov 27, 2024	ANTX AN2 Therapeutics, Inc.	Purchase(P)	25,000	$1.42	$35,423	Indirect
Nov 27, 2024	ANTX AN2 Therapeutics, Inc.	Purchase(P)	25,000	$1.42	$35,418	Indirect
Nov 26, 2024	ANTX AN2 Therapeutics, Inc.	Purchase(P)	12,500	$1.39	$17,418	Indirect
Nov 26, 2024	ANTX AN2 Therapeutics, Inc.	Purchase(P)	12,500	$1.39	$17,428	Indirect

1-25 of 29 transactions

About Readnour Robin Shane

Readnour Robin Shane (SEC CIK 0001914883) files insider reports with the SEC as Director of AN2 Therapeutics, Inc. (ANTX).

Signal8 holds 10 ownership filings by Readnour Robin Shane, all Form 4s, filed between Nov 21, 2024 and Sep 11, 2026. Those filings report 29 transactions, from Nov 19, 2024 to Sep 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Readnour Robin Shane's filings is in MENLO PARK, CA.

Recent filings by Readnour Robin Shane

Sep 9, 2026: Open-market sales of ANTX shares (2 lines, Form 4, code S).
Sep 8, 2026: Open-market sales of ANTX shares (2 lines, Form 4, code S).
Sep 3, 2026: Open-market sales of ANTX shares (2 lines, Form 4, code S).
Aug 17, 2026: Open-market sales of ANTX shares (2 lines, Form 4, code S).
Mar 19, 2026: Disposition to issuer transaction of ANTX derivative securities (Form 4, code D).

Other insiders filing for AN2 Therapeutics, Inc. (ANTX)

Marks Gilbert Lynn, Director
Martin Patricia A., Director
Aziz Kabeer, Director
Trenor Cameron C. III, Chief Medical Officer
Williams Sarah Joanne, Principal Accounting Officer
FitzPatrick Margaret M, Director

How to read Form 4 transaction codes